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Abstract  
Objective To investigate the degradation pattern of a porcine non-cross-linked collagen 
membrane in an in vivo model of guided bone regeneration (GBR). 
Background Although collagen membranes have been clinically applied for guided 
tissue/bone regeneration for more than 30 years, their in vivo degradation pattern has never 
been fully clarified. A better understanding of the different stages of in vivo degradation of 
collagen membranes is extremely important, considering that the biology of bone 
regeneration requires the presence of a stable and cell/ tissue-occlusive barrier during the 
healing stages in order to ensure a predictable result. 
Methods Decalcified and paraffin-embedded specimens from calvarial defects of eighteen, 
10-month old Wistar rats were used. The defects were treated with a double layer of collagen 
membrane and a deproteinized bovine bone mineral (DBBM) particulate graft. At 7, 14 and 
30 days of healing, qualitative evaluation with scanning electron microscopy (SEM) and 
atomic force microscopy (AFM) and histomorphometric measurements were performed. 
Markers of collagenase activity and bone formation were investigated with 
immunofluorescence technique.  
Results A significant reduction of membrane thickness was observed from 7 to 30 days of 
healing, which was combined to a progressive loss of collagen alignment, increased collagen 
remodelling and progressive invasion of woven bone inside the membranes. A limited 
inflammatory infiltrate was observed at all healing points. 
Conclusion The collagen membrane investigated was biocompatible and able to promote 
bone regeneration. However, pronounced signs of degradation were observed starting from 
day 30. Since successful regeneration is obtained only when cell occlusion and space 
maintenance exist for the heling time needed by the bone progenitor cells to repopulate the 
defect, the suitability of collagen membranes in cases where long-lasting barriers are needed, 
needs to be further reviewed. 
 
 
 
 
  
Introduction 
The use of a barrier membrane to promote the selective repopulation of a periodontal/bone 
defect by cells with a regenerative rather than reparative potential has been successfully 
applied for more than forty years (1). In particular, in Guided Bone Regeneration (GBR), the 
surgical placement of a tissue occlusive membrane has been applied for the predictable 
treatment of atrophic ridges, peri-implant defects, for socket preservation and for de novo 
bone formation in healthy and medically compromised conditions (2-5) (for review see (6, 7)). 
An ideal barrier for GBR should combine biocompatibility and tissue conclusiveness with 
clinical manageability, space maintenance and the possibility to gradually resorb overtime (8). 
Collagen forms a significant part of the body and of the connective tissue's proteins and it is 
continuously remodelled by specific enzymes called collagenases (9). Collagen-based 
membranes can be obtained from human skin, bovine Achilles tendon or porcine skin, and 
inner organs (10). Their advantages in comparison to non-resorbable membranes are several: 
a simplified one-stage surgical procedure, cost-effectiveness, decreased patient morbidity, a 
quick resorption in case of exposure, and an improved soft tissue healing. Nevertheless, it is 
difficult to predict and control the duration of maintaining occlusive properties, and this can 
unfavorably interfere with the bone healing process (11-13). Another disadvantage of 
collagen membranes is related to their unfavourable mechanical properties, which leads to 
collapse into the bony defects, hence their combination with a bone graft is recommended 
when clinically applied (14, 15). 
Although the application of collagen membranes in guided bone/tissue regeneration is well 
established in clinical practice, surprisingly only a limited number of studies have investigated 
their resorption pattern and they have shown that the degradation of collagen membranes 
might start within 4 days to 6 weeks after surgical placement (16-18). However, in most of 
the published studies collagen membrane resorption was evaluated after subcutaneous 
implantation (17, 19-21), which does not resemble the clinical milieu, where the membrane 
is in direct contact with the pristine bone, the graft and the soft tissues within the context of 
a surgical osseous wound. Moreover, the available data mainly consists in qualitative 
histologic observations and/or on the measurement of the membrane thickness, with little 
characterization of the enzymatic degradation process (12, 16, 22).  
Hence, the aim of this study was to investigate qualitatively and quantitatively the early and 
late degradation of a commonly used porcine collagen type I and III membrane associated to 
a bovine osteoconductive graft in an in vivo model for GBR.  
 
Materials and Methods 
 
This study was carried out on rat samples obtained as part of a previously approved project 
(23, 24). The protocol was approved by the Ethical Committee of the General Directorate for 
Agricultural Economy and Veterinary Medicine of Athens, Greece (protocol number 590), and 
was carried out in accordance with EU Directive 2010/63/EU for animal experiments. The 
ARRIVE guidelines for reporting animal research were followed (25).  
 
Experimental GBR model 
Eighteen 10-month old, Wistar rats were used. After two weeks of acclimatization the 
experimental GBR surgical procedure was performed, as previously described (23). Briefly, a 
standardized 5.0-mm of diameter critical size defect (CSD) was created on each parietal bone 
by the use of a trephine burr. A porcine collagen membrane (Geistlich Bio-Gide, Wolhusen, 
Switzerland) was trimmed and adapted to the intracranial part of the defects, a deproteinized 
bovine bone mineral (DBBM) graft (Geistlich Bio-Oss, Wolhusen, Switzerland) was than 
loosely compacted into the defect and eventually covered by a second resorbable collagen 
membrane (Geistlich Bio-Gide, Wolhusen, Switzerland). The flap was sutured in layers 
(Vicryl 5.0, Ethicon, Cincinnati, OH, USA). Six animals were randomly sacrificed at 7, 14 and 
30 days of healing. During the sacrifice, one defect was randomly chosen for decalcified 
histology and one for proteomic analysis (results described in (23, 24)). 
 
Histology analysis and histomorphometric measurements 
The three most central sections of each sample were stained with hematoxylin and eosin and 
one section was stained with Masson trichrome staining and the following evaluations were 
performed by a blind, previously trained examiner with a light microscope (Olympus BX50, 
Olympus America, Inc., Center Valley, PA, USA) connected to a digital color camera 
(CoolSNAP-Pro Media Cybernetics Inc., Marlow, Buckinghamshire, UK): 
1. Qualitative descriptive histology at different magnifications (X4, X10, X20, X40). One 
section of each sample was also stained with picrosirius red and qualitatively 
examined under polarized light. This stain allows to distinguish aligned (red) and not 
aligned (green) collagen fibers (26). 
2. General and specific tissue reaction: in three regions of interest (ROI) (one at one end, 
one at the opposite end and one in the middle) according to Bozkurt et al (20). Details 
of the parameters evaluated and of the scoring system are presented in Table 1.  
Thickness of the upper and lower collagen membrane (micron): measured with the 
help of the software Image-Pro Plus (Version 4.5.0, Media Cybernetics Inc., Marlow, 
Buckinghamshire, UK) at X4 magnification in three areas alongside the full length of 
each membrane (two at the margin of the defect and one in the middle). The mean 
value was calculated for the extracranial and intracranial membranes. Moreover, the 
thickness of an intact dry collagen membrane (DM) (Geistlich Bio-Gide, Wolhusen, 
Switzerland) and of an intact collagen membrane that was processed and embedded 
into paraffin (PM) were measured.  
Atomic force microscopy (AFM) and scanning electron microscopy (SEM) 
An intact porcine collagen membrane and two randomly selected samples per healing point 
were qualitatively assessed with AFM and SEM. The histology sections used for AFM, were 
firstly stained with picrosirius red, then imaged using light microscopy to identify red, yellow 
and green areas. Once the areas were identified, AFM contact imaging in air was performed 
using Dimension 3100 and Dimension Icon AFMs (Bruker), with MSNL-10 probes. The sections 
used for SEM were fixed with 3% glutaraldehyde for 24 hours, dehydrated in an ethanol 
series, mounted on stubs and coated with gold/palladium. Sections were then imaged on a 
Philips XL30 FEG-SEM, with an acceleration voltage of 5kV. 
 
Immunofluorescence analysis 
The following antibodies were applied for immunofluorescence analysis on 3 randomly 
selected samples per group: 
- MMP-1 (Bioss bs-0463R), MMP-8 (Bioss bs-1913R) and TIMP-1 (Santa Cruz Biotechnology, 
Inc. sc-6834) as collagenase activity markers; 
- TNF-α (Bioss bs-2081R), IL-1β (Neuromics Antibodies GT15102) as inflammation markers; 
- osteopontin (Bioss bs-0026R), bone sialoprotein (Bioss bs-4729R) and osteocalcin (Bioss bs-
4917R) as new bone formation markers; 
- Vimentin (Bioss bs-3471R) as mesenchymal cell marker. 
Three sections per animal were used, in order to have triplicates of the results. The sections 
were treated with boiling EDTA buffer and maintained at 80 °C for 10 minutes for antigen 
retrieval. After reaching RT, the blocking step was carried out with 5% BSA in PBS for 30 
minutes. The sections were incubated with the primary antibodies diluted 1:50 in PBS 
containing 5% BSA over night at 4°C. After a washing step, the secondary antibody (Jackson 
ImmunoResearch Laboratories) was added. Finally, the sections were stained with DAPI for 5 
minutes and then were mounted with anti-fading medium. A standard DAPI-FITC-TRITC 
combination filter was used to assess the positivity for the aforementioned antibodies. 
A semi-quantitative scoring system was applied as follows: -, when less than 10% positivity 
was detected; +, for 10% positive cells; ++, for  25% positive cells and +++, for  50% positive 
cells(modified from (27)). 
 
Statistical analysis and sample size 
In light of the “reduction” principle in animal research, for this project we used samples of a 
previously approved study that aimed at describing histologically and at a proteomic level the 
process of bone regeneration in healthy and osteoporotic-like rats (23, 24). Hence, sample 
size was not calculated based on a specific membrane degradation parameter. 
Differences in membrane thickness (micron) at the different healing periods were 
investigated with one-way ANOVA (SPSS software, IBM Corp. Released 2013, Version 22.0. 
Armonk, NY: IBM Corp.). Post-hoc Tukey test was applied to explore differences in means 
between the healing times. 20% of the samples were measured again the after 1 week from 
the first evaluation and the reproducibility was tested with the Bland and Altman diagram, 
the calculation of the British Standards Institution repeatability coefficient and Lin’s 
concordance correlation coefficient. The general and specific tissue reactions, as well as the 
immunofluorescence markers were graphically presented in summary tables. 
 
Results 
 
Qualitative histology 
At 7 days, the margins of the defects were clearly detectable and both collagen membranes 
were in place and well preserved in all specimens. The penetration of body fluids had given 
the membranes a “spongy” aspect, with initial separation between the collagen bundles. The 
most prevalent cells were erythrocytes, although a few polymorphonuclear leukocytes and 
lymphocytes were also identified. The picrosirius red stain showed widespread red areas in 
both intracranial and extracranial membranes, with only isolated green spots amongst the 
red fibers, thus identifying an overall aligned collagen structure (Figure 2, a and a-1). 
At 14 days, initial signs of breakdown of the eosinophilic collagen bundles (especially in the 
upper membrane) were identified. A limited infiltrate of polymorphonuclear leukocytes, 
lymphocytes and macrophages was observed through the whole thickness of both 
intracranial and extracranial membranes. The sections stained with picrosirius showed an 
increasing amount or green spots within the red collagen bundles (Figure 2 b and b-1). 
At 30 days, both intracranial and extracranial membranes were infiltrated by a few pyknotic 
cells (mainly polymorphonuclear leukocytes and lymphocytes) and marked signs of 
dissolution/degradation were detectable. In particular, the eosinophilic collagen bundles 
were fragmented in short and scattered clusters, with new vessels penetrating them. Close 
to the defect margins it was also possible to identify new bone formation spreading from the 
margins of the defect into the membranes, thus embedding the collagen fibers. The 
picrosirius stain confirmed a general loss of collagen register, with diffuse orange and green 
areas throughout the membranes and limited red areas (Figure 2 c and c-1). 
 
General and specific tissue reaction 
The general tissue reaction score showed the presence of a significant hemorrhage infiltrate 
both at 7 and 14 days and an increasing number of blood vessels in both intracranial and 
extracranial membranes from 7 to 30 days of healing (Table 1). A higher number of blood 
vessels was observed in the extracranial membrane, particularly at day 30.  
The specific tissue reaction indicated a limited inflammatory reaction, as at neither of the 
healing periods we identified a score higher than 0.5, which indicates an average number of 
cells <10 in the regions of interest. The identified cells consisted mainly in polymorphonuclear 
leukocytes, lymphocytes and macrophages.  
Representative histological microphotographs obtained with different histological stainings 
at 7, 14 and 30 days of healing are presented in Figure 3 in order to support the data 
presented in Table 1.  
Membrane thickness 
The thickness of both intracranial and extracranial membranes significantly reduced from 7 
to 30 days of healing (Figure 1).  
Although the extracranial membrane tended to present a reduced thickness in comparison to 
the intracranial one, this trend was not statistically significant. In comparison to the intact 
control sample processed and embedded into paraffin (PM), both extracranial and 
intracranial membranes showed an increased thickness at 7 day, that reduced to 
approximately the same thickness of PM at 14, and then further reduced at 30 days of healing.  
The reproducibility of the measurements was fairly accurate, with a non-statistically 
significant difference between the first and second readings of ?̅? = -0.005 mm (SD 0.014 mm) 
for the extracranial membrane and of  ?̅? = -0.011 mm (SD 0.019 mm) for the intracranial 
membrane. The British Standards Institution repeatability coefficient was 0.028 mm and 
0.038 mm, respectively and the Lin’s correlation coefficient was 0.997 (95% CI 0.991-0.999) 
and 0.996 (95% CI 0.986-0.999), respectively. 
 
AFM and SEM 
At day 7, only a loose collagen network could be seen in both extracranial and intracranial 
membranes at SEM. This network was highly porous with thin fibrils, but a large infiltration 
of erythrocytes and limited neutrophils was present (Figure 4a). The AFM returned an 
irregular picture, but it was possible to identify areas where collagen bundles were still visible 
(Figure 3d) 
At day 14, a less porous collagen network was observed, with an increase in the quantity of 
fibrils. Erythrocytes were still present and embedding both membranes (Figure 4b). 
Remarkably, collagen fibrils were also organizing around the graft particles inside the defect 
area.  
At day 30, the collagen network size had increased again in both membranes, with few pores 
observed. Infiltration of various cell types was observed, with signs of colliquation of the 
collage membranes (Figure 4c). At high magnification, it was impossible to distinguish the 
peculiar collagen bundle structure, but both membranes were infiltrated by areas of 
mineralization and what appeared as a denser tissue network.  
AFM pictures at 14 and 30 days did not provide good quality data, owing to the irregular 
surface of the samples, and It was impossible to identify collagen fibrils. 
 
Immunofluorescence analysis 
The markers of collagenase activity (MMP-1, MMP-8 and TIMP-1) showed no positivity at day 
7, whilst punctiform positivity was detected at day 14, which significantly increased at day 30 
(Figure 5). On average, at 14 days, 10% of cells were positive to MMP-1 and TIMP-1 within 
the defect area, while  25% cells were positive to MMP-1 and MMP-8 and 10% of cells were 
positive to TIMP- within the membranes. At 30 days, the positivity to collagenase markers 
further increased within the membranes, with 50% of cells positive to MMP-1 and  25% 
cells positive to MMP-8 (Table 2). The positivity was mainly observed in proximity to the 
membrane elastic fibers. 
Markers of inflammation (TNF-α and IL-1β) were not detected (or <10% of positive cells) 
neither in the membranes nor in the defect area at all healing periods (Table 2). 
Markers of bone formation were identified starting from day 14 both in the defect and within 
the membranes (Figure 6). At 14 days,  10% cells within the defect were positive to 
osteopontin and osteocalcin, whist  25% cells were positive to bone sialoprotein. At 30 days, 
 10% cells within the defect were positive to osteopontin and  20% cells were positive to 
bone sialoprotein and osteocalcin (Table 2). In the defect area, most of the fluorescent spots 
were identified in close proximity to the DBBM graft particles. In the membranes, the 
positivity started at 14 days and reached the highest scores at 30 days for all markers, when 
 20% cells were positive to bone sialoprotein and osteopontin and   10% cells were positive 
to osteocalcin (Table 2).  
Vimentin was expressed in the defect area in 10% of the cells at day 14, whilst at 30 days a 
moderate positivity (10% cells) was found in the membrane area (Table 2).  
 
Discussion 
 
The porcine type I and III collagen membrane adopted was biocompatible and inert, did not 
elicit an inflammatory or foreign body reaction, and was able to positively promote the bone 
regeneration process. Membrane integrity was well maintained during the first 14 days, but 
at 30 days pronounced signs of degradation, high levels of remodeling and a significant 
reduction in thickness were identified. These data confirm previous findings in a similar model 
from Moses et al (22) that showed a significant reduction in membrane thickness from 14 to 
30 days of healing, as well as a significant reduction in the total amount of collagen. 
Remarkably, at 30 days, bone formation markers (ALP, BS, OPN), mesenchymal cell marker 
(Vimentin) and histology features suggested that bone formation was spreading inside the 
membranes and embedding the fragmented collagen bundles. While this implies a loss of 
integrity as a barrier, at the same time the membrane was able to support the bone 
regeneration process (23) and to create an environment that promoted the deposition and 
mineralization of the bone matrix, with blood vessels penetrating throughout the membrane 
at 30 days. A recent study in a similar calvaria defect model also confirmed that, at 30 days of 
healing, the collagen membrane network is progressively invaded by areas of bone formation 
and presents a dense infiltrate of leukocytes and fibroblast-like cells (28). 
The trend for a higher resorption of the extracranial compared to the intracranial membrane 
observed in our study might be justified by the increased number of blood vessels detected 
in the extracranial barrier. The vessels originating by the overlaying periosteum and inner skin 
might have, in fact, contributed to accelerate the resorption of the extracranial barriers. Our 
results are in line with previous studies reporting that the porous structure of non-cross-
linked collagen membranes is suitable for the formation of trans-membrane blood vessels, 
which may also facilitate membrane resorption (12, 21, 29). Recently, Turri et al have also 
shown that collagen membranes act as bioactive compartments rather than passive barriers, 
as they are involved in attracting cells into the wound area, which secrete signals for bone 
regeneration and remodeling, and they promote the expression of chemotactic factors, thus 
modulating the overall osteogenic process (30). 
Throughout the SEM images taken of the collagen membrane, a clear pattern of healing could 
be observed from 7 to 30 days. Firstly, the collagen network increased in size, with individual 
fibrils being harder to see as the network grew and the porosity reduced. The increase in the 
amount of collagen could be linked to the recovery and maturation of the wound area, as it 
went in parallel with the progressive increase in the amount of bone formation and 
maturation of the newly formed bone (histomorphometric data presented in (23)). Secondly, 
the apparent cell makeup in the network changed over time. Initially, there was a large 
contribution from erythrocytes, but as the healing progressed, more leukocytes, eosinophils 
and neutrophils were detected at the healing site.  
The collagen remodelling was confirmed by the immunodetection of Matrix 
Metalloproteinases (MMP) 1 and 8. The remodelling process is necessary for the wound 
healing process. Leukocytes, particularly macrophages and neutrophils, are major sources of 
MMP production (31, 32). Other cells involved in the postacute stages of wound healing can 
also contribute to MMP release, such as fibroblasts and endothelial cells (33). Most MMPs 
are not constitutively expressed in normal tissues, but inflammatory cytokines, such as IL-1 
and TNF, or growth factors, such as TGF-beta, and noxious stimuli are required to initiate the 
transcription (34-36). In this study, the high positivity for MMP-1, MMP-8 and TIMP-1 found 
at the later healing periods was not associated to a high inflammatory infiltrate, and the IL-
1 and TNF- markers did not return significant positivity (or a positivity <10%) at all healing 
times. The lack (or low) of positivity for IL-1 and TNF- might be related to the sample 
processing. It is well-known that the decalcification and processing of the samples are antigen 
masking (37) and that different antigens may show immunoreactivity differences in relation 
to time and preservation of the samples (38), so it is possible that a weak positivity for 
inflammatory markers might have been concealed or, at least reduced. Previous studies have 
also shown that osteoblasts and osteocytes express MMPs and TIMP1 in the course of 
appositional bone formation (39), so our data on MMPs expression at 14 and 30 days also 
suggest a maturing osseous wound. 
Since a control group without bone graft particles was not present, we do not know if the 
graft influenced collagen barrier degradation in terms of MMP expression. Previously, Elgali 
et al (40) tested the early events of bone healing and the cellular activities in response to a 
combination of GBR membrane and different bone substitute materials. No data about MMP 
activity was reported, but the study showed that the defects treated with a collagen 
membrane and the defects treated with a combination of collagen membrane and 
deporteinized bovine bone had similar expression of osteoclasts and inflammatory markers. 
Only at 12 hours it was possible to detect a temporary higher expression of RANKL in the 
defects covered only by the membrane and a higher expression of TNF- in the defects where 
the graft was also applied. However, at later healing points no significant differences were 
detected. 
To the best of our knowledge, this is the first study that thoroughly evaluated the degradation 
of a collagen membrane by qualitative histology, by qualitative SEM and AFM evaluations, by 
antigen-antibody characterizations and histomorphometry in an in vivo model that is a close 
approximation of the clinical scenario where this membrane is commonly applied and in 
combination with a particulate bone graft. Previously, Rothamel et al (18) studied the 
degradation of two collagen membranes associated to different bovine bone grafts. The 
authors only performed qualitative histological and SEM observations, but their results are in 
line with ours in terms of low inflammatory reaction, early vascularization and limited cell 
proliferation  
DBBM has been successfully applied in combination with membranes in numerous human 
bone regeneration and augmentation studies (3, 41-44). The use of DBBM does not enhance 
per se the capacity of the membrane to promote bone formation, but it demonstrates 
osteoconductive properties and mechanically supports/provides space maintenance to the 
barrier against its collapse into the defect (45, 46). In the current project, the marked 
positivity to osteopontin, bone sialoprotein and osteocalcin around the DBBM particles 
corroborated the osteoconductivity of this graft.  
In clinical practice, successful regeneration is obtained only when cell occlusion and space 
maintenance exist for the heling time needed by the progenitor cells to repopulate the defect. 
While in periodontal regeneration a period of 6 to 8 weeks might be sufficient (47), a longer 
period up to 6 months has been advocated for bone regeneration (48, 49). Hence, future 
studies considering longer healing periods are warranted to test the degradation process of 
collagen membranes in GBR models. 
Nevertheless, good long-term clinical results have been documented when collagen 
membranes without a prolonged barrier function were combined with autologous bone chips 
and DBBM for contour augmentation around chemically modified, sandblasted and acid-
etched implants (50). Therefore, the use of the porcine collagen membrane tested in this 
study in GBR needs to be reviewed in light of the new implant surfaces and biomaterials 
adopted and in relation to the clinical application (GBR around implants, for socket 
preservation, or for the regeneration of atrophic ridges).  
In order to increase the stability of collagen membranes and delay their degradation, different 
approaches have been proposed, including cross-linking the collagen (51), applying a double 
layer of membranes (12), using tetracycline impregnation (52, 53) and systemically 
administering tetracycline (54). By modifying surface properties, particle size, porosity and 
the release of ions, future studies should aim at manufacturing an ideal immune-mediated 
collagen membrane that promotes anti-inflammatory M2 macrophages and the secretion of 
regenerative cytokines, whilst at the same time prevents the migration of undesired soft 
tissues into the osseous wound (55). 
The combined approach proposed in the current project to assess membrane degradation 
(quantitative and qualitative histology, immunofluorescence, SEM/AFM) allowed a thorough 
in vivo characterization of collagen degradation and might be successfully used in the future 
to test the behavior of other barrier membranes (e.g. cross-linked collagen membranes). 
Longer healing times are advised in future studies, in consideration of the long-lasting barrier 
effect advocated for GBR.  
Finally, this study investigated barrier degradation during an uneventful healing process. 
However, in clinical practice it is not uncommon to observe membrane exposure (56), 
especially during the early healing stages. As the membrane becomes exposed to the oral 
environment, bacterial enzymatic products and saliva enzymes will trigger a faster 
degradation of the biomaterial, with the possibility that the bacterial colonization of the 
membrane may compromise the final regeneration outcome (57-61). In the future, it would 
be interesting to apply the methodologies developed in this study to investigate also how the 
exposure to the oral environment might influence membrane properties and degradation. 
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Figure legend 
Figure 1 The mean thickness (micron) and standard deviation of the extracranial membrane 
(EM) and intracranial membrane (IM) at the different healing times are graphically presented. 
The thickness of an intact dry membrane (DM) and of a processed membrane (PM) are also 
shown.  indicates significant difference in comparison to 7 days of healing; ⌿  indicates 
significant difference in comparison to 14 days of healing. 
 
Figure 2 Sections stained with picrosirius red. a, a-1, 7-day healing section. At this early 
healing period, both membranes presented aligned (red) collagen. b, b-1, 14-day healing 
section. At this healing time, some green dots were detectable inside the red membrane. c, 
c-1, 30-day healing section. At this later time point, the membrane was almost entirely 
replaced by either non-aligned collagen or a loose granulation tissue resembling woven bone. 
Widespread areas of orange and green were clearly detectable inside both membranes. 
 
Figure 3 Representative histological microphotographs at 7, 14 and 30 days after surgery. a, 
b, c: giemsa staining of samples at the different healing period (asterisks indicate fatty 
infiltrates). d, e, f: masson trichrome staining at different healing period (arrows indicate 
blood vessels; arrowheads indicate extravasated erythrocytes). G, g, i: hematoxylin and eosin 
staining (circular arrowheads indicate inflammatory infiltrate). Scale bar 100 micron.  
 
Figure 4 a, section of 7-days healing period at SEM. At this stage, a loose network of collagen 
fibers was detected, which were infiltrated mainly by erythrocytes and a few 
polymorphonuclear leukocytes and lymphocytes. b, section of 14-days healing period at SEM. 
A more organized network of fibers and cells was detected. c, section of 30-days healing 
period at SEM. Signs of colliquation of the membrane (arrows) and infiltration by different 
cell types were observed. d, Section of 7-days healing period at AFM. The image was taken in 
a “red” area of a section stained with picrosirius red. We can foresee the bundle structure of 
collagen in some areas (arrows), although overall the surface was very irregular and did not 
allow for good quality pictures. 
 
Figure 5 a, d, Immunofluorescent spots indicate cells positive for MMP-1 at 14 (a) and 30 (d) 
days. b, e, Immunofluorescent spots indicate cells positive for MMP-8 at 14 (b) and 30 (e) 
days. c, f, Immunofluorescent spots indicate cells positive for TIMP-1 at 14 and 30 days. All 
markers are identifiable in TRITC. 
 
Figure 6 a, Immunofluorescent spots indicate cells positive for osteopontin (OPN) at 30 days 
(identifiable in TRITC). b, Immunofluorescent spots indicate cells positive for osteocalcin (OC) 
at 14 days (identifiable in TRITC). c, Immunofluorescent spots indicate cells positive for bone 
sialoprotein (BSP) at 30 days (identifiable in FITC). 
 
Table legend 
Table 1 Average details of the general and specific tissue reaction scores according to Bozkurt 
et al (20). The general tissue reaction was evaluated according to the following scoring 
system: - = not present; + = present in 10% of the viewed area, ++ = present in 20% of the 
viewed area and +++ = present in 50% of the viewed area. The number of blood vessels (and 
standard error, SE) in the extracranial and intracranial membranes of each sample was 
counted. The specific tissue reaction was evaluated according to the following scoring system: 
0 = no cells; 0.5 = <10 cells; 1 = 10-50 cells; 2 = 50-90 cells and 3 = >100 cells (and standard 
error, SE). 
 
Table 2 Scores of the immunofluorescence analyses for the collagenase, inflammatory and 
bone formation markers evaluated. The scoring system adopted was the following: -, when 
less than 10% positivity was detected; +, for 10% positive cells; ++, for 25% positive cells 
and +++, for  50% positive cells.  
 
 
 
Parameters 7 days 14 days 30 days 
General tissue reaction     
Fibrosis 
Fatty infiltrate 
Hemorrhage 
Necrosis 
Degeneration 
Foreign debris 
 
Number of blood vessels (SE) 
- 
- 
++ 
- 
- 
- 
 
1.13 (1.55) 
- 
+ 
++ 
- 
- 
- 
 
7.50 (3.42) 
+ 
+ 
+ 
- 
- 
- 
 
11 (11.38) 
Specific tissue reaction (score 0-3 and SE) 
Polymorphonuclear leukocytes 
Lympocytes 
0.38 (0.58) 
0.17 (0.38) 
0.25 (0.44) 
0.58 (0.65) 
0.25 (0.53) 
0.42 (0.58) 
Eosinophils 
Plasma cells 
Macrophages 
Multinucleated giant cells 
0.04 (0.20) 
- 
0.04 (0.20) 
- 
- 
- 
0.08 (0.28) 
- 
- 
- 
0.04 (0.20) 
- 
Table 1 
 
 
 7 days 14 days 30 days 
 Defect Membrane Defect Membrane Defect Membrane 
Collagenase activity 
MMP-1 - - + ++ ++ +++ 
MMP-8 - - - ++ + ++ 
TIMP-1 - - + + ++ + 
Inflammation 
TNF-a  - - - - - - 
IL-1b  - - - - - - 
Bone formation 
Osteopontin - - + - + ++ 
Osteocalcin - - + + ++ + 
Bone sialoprotein - - ++ ++ ++ ++ 
Mesenchymal cell 
marker 
      
Vimentin - - + - - + 
Table 2 
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